COMP <GO>
LIFE vs JPM // EV/EBITDA & P/E VALUATION
Ethos Technologies Inc. (Class A) (NASDAQ) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: LIFE 5
— JPM 6
▲ EV/EBITDA & P/E VALUATION LEADER: JPM
LAST: $43.62 (+1.85%) • MKT CAP: $2.83B
valuation
37.0x
LAST: $343.58 (+1.26%) • MKT CAP: $913.30B
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LIFE VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LIFE | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.60% | 17.37% | +23.23 | LIFE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 37.0x | 9.7x | +27.33 | JPM | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | -18.14% | +19.37 | LIFE | /fcf-yield <GO> |
| Operating Margin | 18.80% | 42.07% | -23.27 | JPM | /operating-margins <GO> |
| Net Profit Margin | 18.40% | 32.63% | -14.23 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | 52.00% | 13.53% | +38.47 | LIFE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.96% | -1.96 | JPM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 2/9 | +4.00 | LIFE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.84% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.1 | 55.1 | +10.04 | LIFE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.00 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.4x | 13.6x | +19.83 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.83B | $913.30B | -$910.47B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LIFE REV | JPM REV | LIFE GROSS % | JPM GROSS % | LIFE FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $387.6M | $182.45B | — | — | $34.7M | -$147.78B |
| FY 2024 | $254.9M | $177.56B | — | — | -$11.7M | -$42.01B |
| FY 2023 | — | $158.10B | — | — | — | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LIFE // BETA —
JPM // BETA 1.00